152 related articles for article (PubMed ID: 1869096)
1. Whole abdomen radiation therapy after a short chemotherapy course and second-look laparotomy in advanced ovarian cancer.
Franchin G; Tumolo S; Scarabelli C; De Paoli A; Boz G; Crivellari D; Arcicasa M; Bortolus R; Gobitti C; Minatel E
Gynecol Oncol; 1991 Jun; 41(3):206-11. PubMed ID: 1869096
[TBL] [Abstract][Full Text] [Related]
2. High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes.
Firat S; Murray K; Erickson B
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):201-7. PubMed ID: 12909234
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: results of a gynecologic oncology group study.
Randall ME; Barrett RJ; Spirtos NM; Chalas E; Homesley HD; Lentz SL; Hanna M
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):139-47. PubMed ID: 12118543
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
[TBL] [Abstract][Full Text] [Related]
5. Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma.
Eifel PJ; Gershenson DM; Delclos L; Wharton JT; Peters LJ
Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):1013-8. PubMed ID: 1917596
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapeutic and surgical induction of pathological complete remission and whole abdominal irradiation for consolidation does not enhance the cure of stage III ovarian carcinoma.
Fuks Z; Rizel S; Biran S
J Clin Oncol; 1988 Mar; 6(3):509-16. PubMed ID: 3127551
[TBL] [Abstract][Full Text] [Related]
7. Toxicity of abdominopelvic radiation in advanced ovarian carcinoma patients after cisplatin/cyclophosphamide therapy and second-look laparotomy.
Shelley WE; Starreveld AA; Carmichael JA; O'Connell G; Roy M; Swenerton K
Obstet Gynecol; 1988 Mar; 71(3 Pt 1):327-32. PubMed ID: 3347416
[TBL] [Abstract][Full Text] [Related]
8. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
[TBL] [Abstract][Full Text] [Related]
9. Whole abdominal radiotherapy following second-look laparotomy for ovarian carcinoma.
MacGibbon A; Bucci J; MacLeod C; Solomon J; Dalrymple C; Firth I; Carter J
Gynecol Oncol; 1999 Oct; 75(1):62-7. PubMed ID: 10502427
[TBL] [Abstract][Full Text] [Related]
10. Whole abdominal irradiation following chemotherapy in patients with minimal residual disease after second look surgery in ovarian carcinoma.
Haie C; Pejovic-Lenfant MH; George M; Michel G; Gerbaulet A; Prade M; Chassagne D
Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):15-9. PubMed ID: 2745190
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal cisplatin chemotherapy versus abdominopelvic irradiation in ovarian carcinoma patients after second look laparotomy. A reassessment based on mature data.
Ben-Baruch G; Menczer J; Feldman B; Rizel S; Brenner H
Eur J Gynaecol Oncol; 1994; 15(4):272-6. PubMed ID: 7957334
[TBL] [Abstract][Full Text] [Related]
12. Abdominopelvic radiotherapy following surgery and chemotherapy in advanced ovarian cancer.
Chiara S; Orsatti M; Franzone P; Scarpati D; Bruzzone M; Repetto L; Vitale V; Conte PF; Rosso R
Clin Oncol (R Coll Radiol); 1991 Nov; 3(6):340-4. PubMed ID: 1742234
[TBL] [Abstract][Full Text] [Related]
13. High-dose, short-duration cisplatin/doxorubicin combination chemotherapy for advanced ovarian epithelial cancer.
Hunter RE; Griffin TW; Stevens S; Roman LD; Bokhari F; Reale FR; Tak WK; Fitzgerald TJ; Dillon MB; Rose PG
Cancer; 1991 Nov; 68(9):1890-4. PubMed ID: 1655227
[TBL] [Abstract][Full Text] [Related]
14. Ten-year follow-up of patients receiving cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced epithelial ovarian carcinoma.
Sutton GP; Stehman FB; Einhorn LH; Roth LM; Blessing JA; Ehrlich CE
J Clin Oncol; 1989 Feb; 7(2):223-9. PubMed ID: 2915238
[TBL] [Abstract][Full Text] [Related]
15. Treatment of ovarian cancer with surgery, short-course chemotherapy and whole abdominal radiation.
Buser K; Bacchi M; Goldhirsch A; Greiner R; Diener P; Sessa C; Jungi WF; Forni M; Leyvraz S; Engeler V
Ann Oncol; 1996 Jan; 7(1):65-70. PubMed ID: 9081394
[TBL] [Abstract][Full Text] [Related]
16. Primary treatment of stage III ovarian carcinoma with sequential chemotherapy and whole abdominal radiation therapy.
Reid GC; Roberts JA; Hopkins MP; Schoeppel SL; Perez-Tamayo C; Drescher C; Chamberlain D; Morley GW
Gynecol Oncol; 1993 Jun; 49(3):333-8. PubMed ID: 8314535
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.
Louie KG; Ozols RF; Myers CE; Ostchega Y; Jenkins J; Howser D; Young RC
J Clin Oncol; 1986 Nov; 4(11):1579-85. PubMed ID: 3095501
[TBL] [Abstract][Full Text] [Related]
18. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
[TBL] [Abstract][Full Text] [Related]
19. Radiation therapy in stage III ovarian cancer following surgery and chemotherapy: prognostic factors, patterns of relapse, and toxicity: a preliminary report.
Arian-Schad KS; Kapp DS; Hackl A; Juettner FM; Leitner H; Porsch G; Lahousen M; Pickel H
Gynecol Oncol; 1990 Oct; 39(1):47-55. PubMed ID: 2227572
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second look.
Bruzzone M; Repetto L; Chiara S; Campora E; Conte PF; Orsatti M; Vitale V; Rubagotti A; Rosso R
Gynecol Oncol; 1990 Sep; 38(3):392-5. PubMed ID: 2227553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
